Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 7Unknown 1Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Leukemia, Myeloid, Chronic-Phase 4Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4Leukemia 3Squamous Cell Carcinoma of Head and Neck 1Meningioma 1Lung Neoplasms 1Leukemia, Promyelocytic, Acute 1Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1Head and Neck Neoplasms 1Glioma 1Glioblastoma 1Esophageal Neoplasms 1Central Nervous System Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Brain Neoplasms 1

Interventions

Cisplatin 22Radiotherapy 15Cetuximab 12Docetaxel 11Carboplatin 10pembrolizumab 8toripalimab 6camrelizumab 6Paclitaxel 5Nivolumab 5Neoadjuvant Therapy 5Fluorouracil 5Drug Therapy 5Chemoradiotherapy 5nimotuzumab 4durvalumab 4Blood Specimen Collection 4sintilimab 3cemiplimab 3apatinib 3advexin 3Surveys and Questionnaires 3Surgical Procedures, Operative 3Immunohistochemistry 3Celecoxib 3nedaplatin 2Therapeutics 2Tegafur 2Radiotherapy, Intensity-Modulated 2Methotrexate 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Squamous Cell Carcinoma of Head and Neck × Hydroxyurea × Clear all
NCT00004094 2014-01-06

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Previously Untreated Advanced Cancer of the Mouth, Pharynx, or Larynx

National Cancer Institute (NCI)

Phase 2 Unknown
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡